No. of Recommendations: 2
https://investors.gamida-cell.com/static-files/9756362b-10ca...

(opens pdf)

two products:
NiCord®: Product candidate for bone marrow transplant with curative potential
NAM-NK Immunotherapy (we'll ignore this for now as it's still early)

NiCord:
-"NAM causes metabolic reprogramming, leading to cell proliferation while preserving stem cells"
---> basically, you mix NiCord with cord blood, and you require way less cord blood / donations.
-addresses 80% of the Allogeneic stem cell transplant Candidate Patient Segmentation (total allogenic transplants = 5,000/yr in US)

Phase 1/2 Study of NiCord® in Patients with Hematologic Malignancies:
• Primary endpoint: Neutrophil engraftment
----> NiCord: 11 days vs 21 days

• Secondary endpoints: Platelet engraftment, acute GvHD, chronic GvHD, infections, hospitalization, non-relapse mortality, overall survival, disease-free survival
-----> Platelet engraftment NiCord: 34 days vs 46 days
-----> decreased infection rate, decrease hospitalization rate
-----> no word no survival / disease free survival

Currently in P3 study for allogenic transplant patients with hematologic malignancies
• Expected enrollment completion: 2H19; Topline data anticipated 1H20

The bad:
- primary end points that are novel and that are NOT morbidity / mortality do not fair as well as trials with morbidity/mortality as the primary endpoint.
-This has been around for awhile when browsing clinicaltrials.gov, but has had poor recruitment, or in some instances hasnt panned out.

The good:
-good potential for better patient outcomes here.
-less patient time in hospital
-one time infusion

The financial:
-TAM about 4,000 patients for hematologic malignancy.
-this might increase the number of transplants since donations can stretch further; also may encourage more transplants.
-about 300-600 new patients a year for aplastic anemia (currently in P1/P2 trials).


I have no idea how much this will cost; but whats the cost of 1-2 weeks in the hospital?? Might be worth looking more into.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.